Newgenivf Group LTD (NIVFW) — 6-K Filings

6-K Filings (32)

• NewGenIvf Group Ltd Reports 9-Month 2025 Results — Dec 2, 2025 Risk: low
  NewGenIvf Group Limited filed a Form 6-K on December 2, 2025, reporting its nine-month results for 2025. The company, formerly known as ASPAC I Mini Acquisition
• 6-K Filing — Nov 25, 2025
• 6-K Filing — Nov 10, 2025
• 6-K Filing — Nov 5, 2025
• NewGenIvf Group Ltd. Reports Interim Results for H1 2025 — Oct 9, 2025 Risk: low
  NewGenIvf Group Limited (NewGen) has filed its Form 6-K for October 2025, reporting its unaudited interim results for the six months ended June 30, 2025. The fi
• NewGenIvf Group Ltd. Announces 1-for-5 Reverse Stock Split — Jul 28, 2025 Risk: medium
  NewGenIvf Group Limited announced a one-for-five reverse stock split, effective August 4, 2025. This action aims to increase the per-share market price of the C
• NewGenIvf Group Ltd Files July 2025 6-K Report — Jul 21, 2025 Risk: low
  NewGenIvf Group Limited filed a Form 6-K on July 21, 2025, reporting for the month of July 2025. The filing includes a press release as Exhibit 99.1. The compan
• NewGenIvf Completes Fifth Debt Financing Tranche — Jul 16, 2025 Risk: medium
  NewGenIvf Group Limited announced on July 16, 2025, the completion of the fifth tranche of its debt financing. This follows the terms of a Securities Purchase A
• NewGenIvf Group Ltd Amends Articles to Increase Share Capital — Jul 7, 2025 Risk: low
  NewGenIvf Group Limited announced on July 4, 2025, that its Board of Directors approved an amendment to its memorandum and articles of association to increase t
• NewGenIvf Group Ltd Files July 2025 6-K Report — Jul 1, 2025 Risk: low
  NewGenIvf Group Ltd filed a Form 6-K on July 1, 2025, reporting for the month of July 2025. The filing includes a press release as Exhibit 99.1. The company, fo
• NewGenIvf Share Count Surges Post-Prospectus — Jun 20, 2025 Risk: medium
  NewGenIvf Group Limited reported on June 20, 2025, that its total issued and outstanding shares have increased to 4,324,565. This includes 4,304,037 Class A ord
• NewGenIvf Group to Present at Emerging Growth Conference — Jun 17, 2025 Risk: low
  NewGenIvf Group Limited will present at the Emerging Growth Conference on June 18, 2025, to provide updates on its digital asset portfolio. This online event of
• NewGenIvf Group Ltd Closes Debt Financing Initial Closing — Jun 4, 2025 Risk: medium
  On June 3, 2025, NewGenIvf Group Limited completed the initial closing of its debt financing. This transaction is part of the Securities Purchase Agreement prev
• NewGenIvf Group Ltd Files June 2025 6-K Report — Jun 2, 2025 Risk: low
  NewGenIvf Group Limited filed a Form 6-K on June 2, 2025, reporting for the month of June 2025. The filing indicates the company is a foreign private issuer and
• NewGenIvf Group Ltd. Announces 1-for-10 Reverse Stock Split — Apr 29, 2025 Risk: medium
  NewGenIvf Group Limited announced a one-for-ten reverse stock split of its issued and unissued shares, effective at 12:01 a.m. ET on Monday, May 5, 2025. This a
• NewGenIvf Group Approves Reverse Stock Split — Apr 16, 2025 Risk: low
  On April 15, 2025, NewGenIvf Group Limited's Board of Directors approved a reverse stock split for all issued and unissued shares, including Class A ordinary sh
• NewGenIvf Director Resigns from Board and Committees — Apr 11, 2025 Risk: low
  NewGenIvf Group Limited announced the resignation of director Mr. Yip Eng Jeremy Foo, effective April 4, 2025. Mr. Foo stepped down from the Board of Directors,
• NewGenIvf Group Ltd. Announces Securities Purchase Agreement — Apr 3, 2025 Risk: medium
  On April 1, 2025, NewGenIvf Group Limited entered into a Securities Purchase Agreement with certain investors (the "Buyers") to sell shares. The agreement inclu
• NewGenIvf Group Ltd Files February 2025 6-K Report — Feb 20, 2025 Risk: low
  NewGenIvf Group Limited filed a Form 6-K on February 20, 2025, reporting for the month of February 2025. The filing includes a press release as Exhibit 99.1. Th
• NewGenIvf Group Ltd Approves Reverse Stock Split — Jan 31, 2025 Risk: medium
  NewGenIvf Group Ltd announced on January 21, 2025, that its Board of Directors approved a reverse stock split for all issued and unissued shares, including Clas
• NewGenIvf Group Ltd Files January 2025 6-K Report — Jan 21, 2025 Risk: low
  NewGenIvf Group Limited filed a Form 6-K on January 21, 2025, reporting for the month of January 2025. The filing includes a press release as Exhibit 99.1. The
• NewGenIvf Appoints Independent Director to Board — Dec 3, 2024 Risk: low
  NewGenIvf Group Limited announced on November 29, 2024, the appointment of Tam, Chun Wa as an independent director to its Board of Directors. Mr. Tam has also b
• NewGenIvf Group Ltd Files November 2024 6-K Report — Nov 22, 2024 Risk: low
  NewGenIvf Group Limited filed a Form 6-K on November 22, 2024, reporting for the month of November 2024. The filing includes a press release as Exhibit 99.1. Th
• NewGenIvf Group Ltd Files 6-K Report — Nov 18, 2024 Risk: low
  NewGenIvf Group Limited filed a Form 6-K on November 18, 2024, reporting information for the month of November 2024. The filing includes a press release as Exhi
• NewGenIvf Completes Third Debt Financing Tranche — Nov 15, 2024 Risk: medium
  NewGenIvf Group Limited announced on November 11, 2024, the completion of the third tranche of its debt financing. This follows the terms of a Securities Purcha
• NewGenIvf Appoints New Auditor for FY2024 — Sep 4, 2024 Risk: low
  NewGenIvf Group Limited announced on September 3, 2024, the appointment of J&S Associate as its independent registered public accounting firm for the fiscal yea
• NewGenIvf Completes Second Debt Financing Tranche — Aug 30, 2024 Risk: medium
  NewGenIvf Group Limited announced on August 28, 2024, the completion of the second tranche of its debt financing. This follows the terms of a Securities Purchas
• NewGenIvf Group Ltd. Announces Securities Purchase Agreement — Aug 16, 2024 Risk: medium
  On August 7, 2024, NewGenIvf Group Limited entered into a Securities Purchase Agreement with certain investors, referred to as the "Buyers," to sell securities.
• NewGenIvf Group Ltd Files 6-K Report — Jun 3, 2024 Risk: low
  NewGenIvf Group Limited, formerly ASPAC I Mini Acquisition Corp., filed a Form 6-K on June 3, 2024. The filing includes a press release as Exhibit 99.1. The com
• NewGenIvf Receives Nasdaq Minimum Bid Price Deficiency Letter — May 28, 2024 Risk: medium
  NewGenIvf Group Limited received a deficiency letter from Nasdaq on May 24, 2024, regarding a minimum market value of publicly held shares. The company is requi
• NewGenIvf Group Ltd Explores Acquisition, Plans $1.5M Private Placement — Apr 22, 2024 Risk: medium
  On April 17, 2024, NewGenIvf Group Limited entered into a non-binding term sheet with European Wellness Investment Holdings Limited (EWIHL) for the potential ac
• NewGenIvf Group Ltd Files 6-K Report — Apr 4, 2024 Risk: low
  NewGenIvf Group Limited, formerly A SPAC I Mini Acquisition Corp., filed a Form 6-K on April 4, 2024. The filing is a report of a foreign private issuer for the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX